Capital is but the accumulated result of the work of our hands. Yet the sword of capital is forever directed against the throat of labor.
Peter Mcguire 1880's
Merck In The News
BASF Announces Purchase of Merck's Electrolyte Business for High-Performance ... - Azom.com
BASF Announces Purchase of Merck's Electrolyte Business for High-Performance ...
Azom.com
By Cameron Chai BASF has announced that it will purchase Merck's electrolytes business for high-performance batteries. Merck is a chemical and pharmaceutical company in Germany. The products and technologies for improving the performance of the battery ...
Merck Millipore introduces AFS 10E and AFS 15E - Laboratory Talk
Merck Millipore introduces AFS 10E and AFS 15E
Laboratory Talk
The new systems are designed to provide an economical and reliable pure water solution for clinical analysers. They integrate patented Elix electrodeionisation (EDI) technology with several other complementary water purification techniques including ...
The Statute of Limitations for Securities Fraud - JD Supra (press release)
The Statute of Limitations for Securities Fraud
JD Supra (press release)
This article reviews the US Supreme Court's decision in Merck & Co., Inc. v. Reynolds, 130, S.Ct. 1784, 176 L.Ed2d 582 (2010). The Court in Merck construed the statute of limitations for securities fraud under Section 10(b ) of the Securities and ...
Protein Sciences Licenses Proprietary expresSF+® Insect Cell Technology to Merck - Bradenton Herald
Protein Sciences Licenses Proprietary expresSF+® Insect Cell Technology to Merck
Bradenton Herald
By Protein Sciences Corporation MERIDEN, Conn., Feb. 22, 2012 — /PRNewswire/ -- Protein Sciences Corporation ("Protein Sciences") announced today that it has granted Merck, through a subsidiary, a non-exclusive license to Protein Sciences' proprietary ...
Merck pens license deal with Protein SciencesMass High Tech
all 8 news articles »
Prospect of single market buoys Merck - The Nation
Prospect of single market buoys Merck
The Nation
Merck, the Germany-based pharmaceutical and chemical giant, sees a good opportunity to grow its business in Southeast Asia thanks to the single-market framework, which will facilitate regional trade of its products. Aman Bhattacharjee, managing ...
and more »
Scholarships available to Kansas students - CattleNetwork.com
Scholarships available to Kansas students
CattleNetwork.com
The Kansas Livestock Foundation (KLF), in conjunction with Merck Animal Health and GoBob Pipe & Steel, is offering several scholarships for the 2012-13 school year. Merck Animal Health annually provides funds for several Ralgro Wheels for Bucks ...
Merck to File Application for Insomnia Drug - Sleep Review
Merck to File Application for Insomnia Drug
Sleep Review
Merck provided an update on the development program for suvorexant, the company's investigational orexin receptor antagonist, which, if approved, will be a new mechanism for the treatment of insomnia. The two pivotal Phase III efficacy trials for ...
Merck pens license deal with Protein Sciences - Mass High Tech
Merck pens license deal with Protein Sciences
Mass High Tech
By Patricia Resende, Correspondent Protein Sciences Corp.has closed a non-exclusive deal with Merck & Co. Inc. to license its insect cell line to use in Merck's vaccine research. The pharmaceutical giant, through a subsidiary, has also secured an ...
Protein Sciences Licenses Proprietary expresSF+® Insect Cell Technology to MerckBradenton Herald
all 8 news articles »
Interviewed Thought Leaders Expect Dalcetrapib and Anacetrapib to Deliver ... - MarketWatch (press release)
Interviewed Thought Leaders Expect Dalcetrapib and Anacetrapib to Deliver ...
MarketWatch (press release)
Clinical data and the opinions of interviewed thought leaders indicate that Roche/Japan Tobacco's dalcetrapib and Merck's anacetrapib will have advantages on these attributes over Merck's Zetia, the sales-leading agent for statin add-on/alternative ...
and more »
Interviewed Thought Leaders Expect Dalcetrapib and Anacetrapib to Deliver ... - MarketWatch (press release)
Interviewed Thought Leaders Expect Dalcetrapib and Anacetrapib to Deliver ...
MarketWatch (press release)
Clinical data and the opinions of interviewed thought leaders indicate that Roche/Japan Tobacco's dalcetrapib and Merck's anacetrapib will have advantages on these attributes over Merck's Zetia, the sales-leading agent for statin add-on/alternative ...
and more »
Interviewed Thought Leaders Expect Dalcetrapib and Anacetrapib to Deliver ... - MarketWatch (press release)
Interviewed Thought Leaders Expect Dalcetrapib and Anacetrapib to Deliver ...
MarketWatch (press release)
Clinical data and the opinions of interviewed thought leaders indicate that Roche/Japan Tobacco's dalcetrapib and Merck's anacetrapib will have advantages on these attributes over Merck's Zetia, the sales-leading agent for statin add-on/alternative ...
and more »
Are You Health Savvy? - FitSugar.com
Are You Health Savvy?
FitSugar.com
Before you go, test your knowledge on Merck's Let's Go There Facebook page to try to separate birth control facts from fiction. Here's a sneak peek: Fact or fiction? All birth control methods are the same. Fiction! Birth control is available in a ...
and more »
Merck Appoints Carat In Indonesia - Asia Media Journal
Merck Appoints Carat In Indonesia
Asia Media Journal
Jakarta: Ernita Ariestanty (Tanty), COO Carat Indonesia, announced today the agency has been appointed to handle PT Merck Tbk Indonesia. PT Merck Tbk is a leading multinational pharmaceutical and chemical business in Indonesia, manufacturing and ...
NCBA Launches Meat Department Training Videos - Supermarket News
Supermarket News
NCBA Launches Meat Department Training Videos
Supermarket News
DENVER — The National Cattlemen's Beef Association and the Beef Checkoff Program here have partnered with Merck Animal Health to launch a series of free, web-based retail training videos geared toward boosting knowledge of beef production and other ...
Consumers often clueless on meat cutsPork Magazine
all 3 news articles »
Threshold Pharma - Pushing Beyond Boundaries - RTT News
RTT News
Threshold Pharma - Pushing Beyond Boundaries
RTT News
Earlier this month, Threshold Pharma signed a global agreement, potentially valued at $550 million, with Merck KGaA, Darmstadt, Germany, to co-develop and commercialize TH-302. The positive phase II results of TH-302 in the pancreatic cancer study ...
Pancreas cancer drug shows promiseHalifax Evening Courier
Threshold dedicates pancreatic cancer results to late officerSan Francisco Business Times (blog)
Threshold Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results ...Lifescience-online
BioWorld Online -NBC Bay Area -MarketWatch
all 60 news articles »
Positive Safety Profile, Too: Threshold Nails PFS Endpoint In TH-302 ... - BioWorld Online
BBC News
Positive Safety Profile, Too: Threshold Nails PFS Endpoint In TH-302 ...
BioWorld Online
The timing couldn't be better for Threshold, which inked a potential $550 million deal earlier this month with Merck KGaA, of Darmstadt, Germany, to develop and commercialize TH-302. (See BioWorld Today, Feb. 6, 2012.) ...
Threshold dedicates pancreatic cancer results to late officerSan Francisco Business Times (blog)
Threshold shares spike over 70% on positive phase 2b pancreatic cancer drug dataProactive Investors USA & Canada
Threshold Pharma - Pushing Beyond BoundariesRTT News
Halifax Evening Courier -FierceBiotech -TheStreet.com
all 58 news articles »
Zacks Investment Research Analysts Reaffirm a "Neutral" Rating on Merck & Co (MRK) - Web Inquirer
Zacks Investment Research Analysts Reaffirm a "Neutral" Rating on Merck & Co (MRK)
Web Inquirer
Merck & Co (NYSE: MRK)'s stock had its “neutral” rating reaffirmed by Zacks Investment Research in a research report issued to clients and investors on Tuesday. They currently have a $40.00 price target on the stock. Zacks' analyst wrote, “Merck posted ...
and more »
Consumer Fraud Class Action Decertified in Drug Case - JD Supra (press release)
Consumer Fraud Class Action Decertified in Drug Case
JD Supra (press release)
See Merck & Co. v. Ratliff, No. 2011-000234 (Ky. Ct. App., 2/10/12). The case involved the drug Vioxx, which was a highly effective medication formerly in widespread use for patients with arthritis and other conditions causing chronic or acute pain.
and more »
Threshold dedicates pancreatic cancer results to late officer - San Francisco Business Times (blog)
BBC News
Threshold dedicates pancreatic cancer results to late officer
San Francisco Business Times (blog)
TH-302, the centerpiece of a commercialization deal earlier this month between Threshold and Merck KGaA, also is in a Phase III trial of patients with soft tissue sarcoma. That deal consisted of a $25 million upfront payment and the potential of $525 ...
Threshold shares spike over 70% on positive phase 2b pancreatic cancer drug dataProactive Investors USA & Canada
Threshold shares spike on positive IIb data for pancreatic cancer drugFierceBiotech
Threshold Drug Delays Pancreatic CancerTheStreet.com
NBC Bay Area -NHS Choices -Wall Street Journal
all 49 news articles »
Supreme Court Balances Access to Information and Third-Party Confidentiality - Blakes
Supreme Court Balances Access to Information and Third-Party Confidentiality
Blakes
Health Canada received access to information requests for documents related to a New Drug Submission and Supplementary New Drug Submission filed by Merck. Merck objected to the disclosure on the basis that the information was exempt under s.
